Skip to content

A randomized, double-blind, placebo-controlled study on the effect of compound rubber seed oil on carotid atherosclerosis

A randomized, double-blind, placebo-controlled study on the effect of compound rubber seed oil on carotid atherosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001520
Enrollment
Unknown
Registered
2026-06-20
Start date
2026-10-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subclinical atherosclerosis

Interventions

experimental group:Take the investigational product orally, 3 capsules before lunch and 3 capsules before bedtime, for a total of 6 capsules per day, continuously for 16 weeks
placebo-controlled:Take the placebo orally, 3 capsules before lunch and 3 capsules before bedtime, for a total of 6 capsules per day, continuously for 16 weeks.

Sponsors

Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: [1] Aged 40–70 years, both males and females eligible; [2] Carotid intima-media thickness (IMT) = 1.0 mm; [3] Signed informed consent form.

Exclusion criteria

Exclusion criteria: [1] Diagnosed with ASCVD (e.g., coronary heart disease, ischemic stroke, peripheral arterial disease); [2] Carotid artery stenosis = 50%; [3] Currently taking statins (e.g., atorvastatin, rosuvastatin); [4] Pregnant or lactating women, or those planning to become pregnant during the trial period; [5] Severe cardiac, hepatic, or renal insufficiency; malignant tumors; mental disorders or cognitive impairment; [6] Known or suspected allergy to the investigational product or its excipients; [7] Participation in another drug clinical trial within 1 month prior to screening/enrollment; [8] Poor compliance as judged by the investigator, or any other condition that, in the investigator's opinion, makes the subject unsuitable for participation in this trial.

Design outcomes

Primary

MeasureTime frame
Carotid Intima-Media Thickness (CIMT);

Secondary

MeasureTime frame
Total carotid plaque area ;Overall treatment response rate ;Lipoprotein-associated phospholipase A2;Total Cholesterol (TC);Triglycerides (TG);Low-Density Lipoprotein Cholesterol (LDL-C);High-Density Lipoprotein Cholesterol (HDL-C);Fasting blood glucose;fasting insulin;Blood pressure ;Routine blood test ;Alanine Aminotransferase (ALT);Aspartate Aminotransferase (AST);uric acid;urea;creatinine;

Countries

China

Contacts

Public ContactGuochong Chen

Soochow University

gcchen@suda.edu.cn15050435888

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026